Harms, limitations explored in Reuters Health's aspirin/colon cancer coverage Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, September 02, 2015

Harms, limitations explored in Reuters Health's aspirin/colon cancer coverage



Harms, limitations explored in Reuters Health

  http://www.healthnewsreview.org/wp-content/themes/hnr2015/img/health-news-review-logo.png

Our Review Summary

A strong story that describes in clear terms the findings as well as the strengths and weaknesses of this study. It covered potential biases that could not be controlled, mentioned harms, and was overall very cautious. It would have been even stronger had it mentioned that the study was observational in nature and therefore not capable of telling us whether the aspirin, or some other factor, is responsible for the benefit that was seen. It also did not mention alternatives for colorectal cancer prevention such as proven effective screening practices. But these are relatively minor omissions in coverage that was otherwise quite exemplary.

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.